Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inhibikase Therapeutics, Inc.

2.25
+0.01000.45%
Post-market: 2.250.00000.00%16:29 EDT
Volume:116.49K
Turnover:264.13K
Market Cap:167.27M
PE:-1.94
High:2.37
Open:2.25
Low:2.20
Close:2.24
Loading ...
Apr 25, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 14, 2025

Major Issues Report

Form 8-K - Current report
Mar 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 24, 2025

Major Issues Report

Form 8-K - Current report
Feb 18, 2025

Major Issues Report

Form 8-K - Current report
Feb 04, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 29, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Correspondence

Form CORRESP - Correspondence
Jan 06, 2025

Major Issues Report

Form 8-K - Current report
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 03, 2024

Correspondence

Form CORRESP - Correspondence
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 28, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 25, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 22, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 22, 2024

Major Issues Report

Form 8-K - Current report